drugset

drugset / Trial / NCT00807781

Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer

NCT00807781 ↗

Phase 1 Completed 15 enrolled Washington University School of Medicine

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety of mammaglobin-A DNA vaccine in metastatic breast cancer patients.

Timeline

Start: 2009-10
Primary completion: 2014-03
Completion: 2014-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	WUSM-MGBA-01	Vaccine	—	Intramuscular

Indications